Evidence mapPaperPMID 34620211Full record

ArticleGenome biology2021

Network propagation-based prioritization of long tail genes in 17 cancer types.

Hussein Mohsen, Vignesh Gunasekharan, Tao Qing, Montrell Seay, Yulia Surovtseva, Sahand Negahban, Zoltan Szallasi, Lajos Pusztai, Mark B Gerstein

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Tumour Genetic Heterogeneity in Relation to Oral Squamous Cell Carcinoma and Anti-Cancer Treatment.International journal of environmental research and public health · 2023
    Review
  10. Article
  11. Article
  12. Cancer Relevance of Human Genes.Journal of the National Cancer Institute · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hussein MohsenComputational Biology & Bioinformatics Program, Yale University, New Haven, CT, 06511, USA. hussein.mohsen@yale.edu.ORCID 0000-0002-6263-8865
Vignesh GunasekharanBreast Medical Oncology, Yale School of Medicine, New Haven, CT, 06511, USA.
Tao QingBreast Medical Oncology, Yale School of Medicine, New Haven, CT, 06511, USA.
Montrell SeayYale Center for Molecular Discovery, Yale University, West Haven, CT, 06516, USA.
Yulia SurovtsevaYale Center for Molecular Discovery, Yale University, West Haven, CT, 06516, USA.
Sahand NegahbanDepartment of Statistics & Data Science, Yale University, New Haven, CT, 06511, USA.
Zoltan SzallasiChildren's Hospital Informatics Program, Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, MA, 02115, USA.
Lajos PusztaiBreast Medical Oncology, Yale School of Medicine, New Haven, CT, 06511, USA. lajos.pusztai@yale.edu.
Mark B GersteinComputational Biology & Bioinformatics Program, Yale University, New Haven, CT, 06511, USA. mark@gersteinlab.org.
Yale University · USHarvard University · USYale Cancer Center · US

Funding

Yale Clinical and Translational Science AwardUL1TR001863 · YALE UNIVERSITY · 2025 to 2025
$9.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

backgroundThe diversity of genomic alterations in cancer poses challenges to fully understanding the etiologies of the disease. Recent interest in infrequent mutations, in genes that reside in the "long tail" of the mutational distribution, uncovered new genes with significant implications in cancer development. The study of cancer-relevant genes often requires integrative approaches pooling together multiple types of biological data. Network propagation methods demonstrate high efficacy in achieving this integration. Yet, the majority of these methods focus their assessment on detecting known cancer genes or identifying altered subnetworks. In this paper, we introduce a network propagation approach that entirely focuses on prioritizing long tail genes with potential functional impact on cancer development.

resultsWe identify sets of often overlooked, rarely to moderately mutated genes whose biological interactions significantly propel their mutation-frequency-based rank upwards during propagation in 17 cancer types. We call these sets "upward mobility genes" and hypothesize that their significant rank improvement indicates functional importance. We report new cancer-pathway associations based on upward mobility genes that are not previously identified using driver genes alone, validate their role in cancer cell survival in vitro using extensive genome-wide RNAi and CRISPR data repositories, and further conduct in vitro functional screenings resulting in the validation of 18 previously unreported genes.

conclusionOur analysis extends the spectrum of cancer-relevant genes and identifies novel potential therapeutic targets.

Indexed as

Genes, NeoplasmCell SurvivalHumansMutationNeoplasmsProtein Interaction Mapping

Identifiers

PMID34620211
PMCPMC8496153
OpenAlexW3204024051

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.